27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Barclays’ Lauren R. Lieberman revised the price targets for several cosmetics companies. Money flows into the Staples sector had lifted valuation multiples since the beginning of 2016, the analyst said. She added, “While we aren’t ones to chase the market, with such a broad elevation in absolute valuation levels, we are revisiting our price targets given our directive to consider our stocks in a relative context.”
Clorox
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Clorox Co (NYSE: CLX) – Underweight rating maintained, price target reduced from $112 to $120
“We are raising our price target on CLX shares to $120 which reflects a ~24x multiple on our C16 EPS estimate of $4.97 and assumes CLX trades in line with Large-Cap CHPC. Our previous price target of $112 assumed CLX traded at a ~22x multiple on our C16 EPS estimate in line with trading peers at the time,” analyst Lauren Lieberman wrote.
Estee Lauder
Estee Lauder Companies Inc (NYSE: EL) – Overweight maintained, price target raised from $94 to $104
On an absolute basis, the company’s shares have not traded above 30x since the early 2000s. Lieberman said, however, that on a relative basis a +30 percent premium has been assigned to “where Large-Cap CHPC is currently trading, which is in line with history.”
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Kimberly Clark
Kimberly Clark Corp (NYSE: KMB) – Overweight maintained, price target raised from $132 to $149
The current price target reflects a ~24x multiple on the EPS estimate of $6.19 for 2016 and assumes the company’s shares trade in-line with Large-Cap CHPC peers. “Our previous price target of $132 reflected the same relative valuation and earnings power, albeit with the group trading at lower levels,” the analyst said.
Colgate-Palmolive
Colgate-Palmolive Company (NYSE: CL) – Equal-weight maintained, price target raised from $69 to $70
The current price target reflects a 25.5x multiple on the EPS estimate of $2.73 for 2016 and assumes the shares trades at a mid-single-digit premium to Large-Cap CHPC.
Procter & Gamble
Procter & Gamble Co (NYSE: PG) – Equal-weight maintained, price target raised from $79 to $82
The current price target reflects a 22.5x multiple on the EPS estimate of $3.66 for 2016 and assumes the company’s shares trade at a mid-single-digit discount to Large-Cap CHPC. “We note that our FY17 EPS estimate is $0.22/sh below current Consensus. Our C2016 estimate is $0.15/sh below Consensus,” the Citi report mentioned.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.